ir.primowater.com
Investor Relations - Primo Water Corporation
Report or Notice of. Day High: 11.79. Day Low: 11.64. 4:00 PM ET on Mar 29, 2018. Delayed at least 20 minutes. Primo Water Corporation (Nasdaq:PRMW) is a leading provider of multi-gallon purified bottled water, self-service refill water and water dispensers sold through major retailers throughout the United States and Canada. Mar 6, 2018. Primo Water Announces Fourth Quarter and Full Year 2017 Financial Results. Feb 13, 2018. Mar 6, 2018 at 4:30 PM ET. Primo Water Fourth Quarter 2017 Financial Results.
ir.progenics.com
Investor Relations | Progenics Pharmaceuticals, Inc.
Skip to main navigation. PSMA Targeted Imaging Compound (1404) Technology. PSMA ADC Therapeutic Technology. Small Molecule Therapeutic Technology. Progenics In The News. 11:33 PM EDT on Mar 29. Progenics Investor relations Team works to provide, shareholders, analysts and potential investors with timely, relevant and reliable information. Mar 22, 2018. Progenics Pharmaceuticals Announces Three-Month Extension of PDUFA Date for AZEDRA (iobenguane I 131). Mar 20, 2018. Legal and Usage Terms.
ir.progroup.ag
Investor Relations
Enter your username and password here in order to log in on the investor website:. Create a new investor login. Access to the restricted area is only available to authorized personnel. If you are already an investor or are interested in our bond, please register via the contact form below. الإمارات العربي ة المت حدة. South Georgia and the South Sandwich Islands. British Indian Ocean Territory. العراق / عي راق. Saint Kitts and Nevis. ශ ර ල ක / இலங க. New Zealand / Aotearoa. Papua New Guinea / Papua Niugini.
ir.projectorganiser.com
Redirecting
Keep me logged in. Keep me logged in. Log in with username.
ir.prologis.com
Prologis
Skip to main content. Stock Quote and Chart. Fixed Income and Corporate Ratings. Stock Quote and Chart. Fixed Income and Corporate Ratings. Annual Net Operating Income. Most Sustainable Companies Globally. Q4 2017 Supplemental Financial Report (PDF). Q1 2018 FINANCIAL RESULT WEBCAST AND CONFERENCE CALL. Prologis to Announce First Quarter 2018 Results April 17. Subscribe to get the latest investor news and information delivered directly to your inbox.
ir.propanc.com
Investor Relations :: Propanc Health Group Corporation (PPCH)
Ended June 30, 2016. Research and development YTD. Net cash used in operations YTD. Jan 11, 2017. Propanc Receives Allowance of Key Patent Application for Method of Treating Solid Tumors in the US. Ended Sep 30, 2016. Sign Up For E-Mail Alerts. View Detailed Stock Info. Propanc Health Group Corporation. View Board of Directors. New York, NY 10022. Corporate Stock Transfer Inc. 3200 Cherry Creek South Drive. Denver, CO 80209. 2016 Propanc Health Group Corporation.
ir.protalex.com
Overview :: Protalex, Inc. (PRTX)
Protalex, Inc. on LinkedIn. Protalex, Inc. on Facebook. Protalex, Inc. on Twitter. Protalex, Inc. on Google Plus. Patents and Intellectual Property. Sign up for email alerts. Be the first to receive breaking news. Protalex Receives Positive Interim Review from Independent Safety Monitoring Committee in Its European Phase 1b Study of PRTX-100 to Treat Immune Thrombocytopenia. May 2, 2016. Nov 30, 2016. Officers & Directors. Arnold P. Kling. Kirk M. Warshaw. Chief Financial Officer, Secretary and Director.
ir.proteontherapeutics.com
Investors | Investors | Proteon Therapeutics
Proteon Therapeutics is a biopharmaceutical company developing vonapanitase. Formerly PRT-201), an investigational drug to improve arteriovenous fistula. PAD) The company is headquartered in Waltham, MA. 160; 0.82. Data as of 08/17/15 4:00 pm ET. Proteon Therapeutics Announces Second Quarter 2015 Financial Results. Proteon Therapeutics Announces Top-Line Results From Phase 1 Study of Investigational Drug Vonapanitase in Patients With Symptomatic Peripheral Artery Disease. Proteon Therapeutics, Inc.
ir.prothena.com
Investor Relations - Prothena Corporation plc
NEOD001 for AL and AA Amyloidosis. PRX002 for Parkinson’s disease. PRX003 for Inflammatory Disease and Metastatic Cancers. Events & Presentations. Financials & Filings. Electronic Delivery ». Day High: 62.47. Day Low: 58.95. Aug 17, 2015. Delayed 20 min., by eSignal. Aug 4, 2015. Prothena Reports Second Quarter 2015 Financial Results and Provides R&D Update. Jun 29, 2015. Prothena Announces Addition of Seasoned Executive to Board of Directors. View all press releases ». 124; Privacy Policy.
ir.provision.tv
Investor Relations :: Provision Holding, Inc. (PVHO)
Total Year End Revenue for the fiscal year ending. June 30, 2016. Nearly 500 kiosks installed in a leading pharmacy chain. Provision Upgrades 3D Savings Center Software. Dec 28, 2016. V20 adds user-friendly loyalty card interface CHATSWORTH, Calif., Dec. 28, 2016 (GLOBE NEWSWIRE) - Provision Interactive Technologies, Inc. ("Provision"), a subsidiary of Provision Holding, Inc. (OTCQB:PVHO),…. 9th Annual LD Micro Main Event. Dec 7, 2016 9:00am PST. Quarter Ended Sep 30, 2016. Sign Up for E-mail. Provision ...
ir.psu.edu
Institutional Research Interest Group – Strengthening IR Community and Capacity at Penn State
Institutional Research Interest Group. Strengthening IR Community and Capacity at Penn State. Welcome to the website of the Penn State Institutional Research Interest Group. We are guided by the belief that although there are many excellent data and analysis resources at Penn State, we can do a better job of coordination, communication, and sharing in the increasingly pertinent domain of institutional research. To keep up to date with upcoming events related to IR. Why an IR Interest Group? Planning Rese...
